Skip to main content

Reproductive Depression and the Response to Hormone Therapy

  • Chapter
  • First Online:
Sex Steroids' Effects on Brain, Heart and Vessels

Part of the book series: ISGE Series ((ISGE))

Abstract

Many cases of depression in women are due to endocrine factors and inappropriate treatment by antidepressants or mood-stabilizing drugs such as lithium. The syndrome reproductive depression includes premenstrual depression (PMDD), postnatal depression (PND) and climacteric depression which is more severe in the transitional phase 2 or 3 years before the periods cease rather than in the years after the menopause. Such patients are usually free of depression during pregnancy. The diagnosis cannot be made by measuring hormone levels but by a careful history relating depression to monthly cycles and the postnatal state. The range and aetiology of depression in women is different than in men and cannot be understood without knowledge of the effect that oestrogen, progesterone and androgens have upon mood. These frequent problems are usually treated badly by psychiatrists who have little knowledge and less interest in the effect of hormones on mood. Treatment should be by oestrogens preferably by the transdermal route possibly with the addition of testosterone and if necessary the addition of progesterone to protect the endometrium.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dickens C. Household words, vol. 95. New York, NY: D. Appleton; 1852. p. 385–9.

    Google Scholar 

  2. Studd J. A guide to hormone therapy for the treatment of depression in women. Climacteric. 2011;14:637–42.

    Article  CAS  Google Scholar 

  3. Studd J, Nappi RE. Reproductive Depression. Gynecol Endocrinol. 2012;28(Suppl 1):42–5.

    Article  CAS  Google Scholar 

  4. Nappi RE, Tonani S, Santamaria V, Ornati A, Albani F, Pisani C, Polatti F. Luteal phase dysphoric disorder and premenstrual syndrome. It J Psych. 2009;28:27–33.

    Google Scholar 

  5. Burger HG, Hale GE, Robertson DN, Dennerstein L. A review of hormonal changes during the menopausal transition. Hum Reprod Update. 2007;13:559–65.

    Article  CAS  Google Scholar 

  6. Craig MC. Should psychiatrist be prescribing oestrogen therapy to their patients? Br J Psychiatry. 2013;202(1):9–13.

    Article  Google Scholar 

  7. Ismaili E, Walsh S, O’Brien PMS, et al. Fourth consensus of the international society of premenstrual disorders (ISPMD): auditable standards for the diagnosis and management of premenstrual disorder. Arch Womens Ment Health. 2016;19(6):953–8.

    Article  Google Scholar 

  8. Wessel Skovlund C, Steinrud Morch L, Vedel Kessing L, Liddegaard O. Association of hormonal contraception with depression. JAMA Psychiat. 2016;73(11):1154–62.

    Article  Google Scholar 

  9. Panay N, Studd J. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update. 1997;3:159–71.

    Article  CAS  Google Scholar 

  10. Watson NR, Studd JWW, Savvas M, Garnett T, Baber RJ. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet. 1989;8665:730–2.

    Article  Google Scholar 

  11. Elovainio M, Teperi J, Aalto AM. Depressive symptoms as predictors of discontinuation of levonorgestrel releasing intrauterine system. Int J Behav Med. 2007;14:70–5.

    Article  Google Scholar 

  12. Leather AT, Studd JW, Watson NR, Holland EF. The treatment of severe premenstrual syndrome with goserelin with and without ‘add-back’ estrogen therapy: a placebo-controlled study. Gynecol Endocrinol. 1999;13:48–55.

    Article  CAS  Google Scholar 

  13. Leather AT, Studd JWW, Watson NR, Holland EFN. The prevention of bone loss in young women treated with GnRh analogues with ‘add back’ oestrogen therapy. Obstet Gynecol. 1993;81:104–7.

    CAS  PubMed  Google Scholar 

  14. Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O’Brien PM. The effectiveness of GnRH analogue with and without “addback” therapy in treating premenstrual syndrome: a meta analysis. BJOG. 2004;111:585–93.

    Article  CAS  Google Scholar 

  15. Di Carlo C, Palomba S, GAm T, et al. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil Steril. 2001;76:850–2.

    Article  Google Scholar 

  16. Casson P, Hahn PM, Van Vugt DA, Reed RL. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am Obstet Gynecol. 1990;162:99–105.

    Article  CAS  Google Scholar 

  17. Cronje WH, Vashisht A, Studd JW. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod. 2004;19:2152–5.

    Article  CAS  Google Scholar 

  18. Studd J. Severe premenstrual syndrome and bipolar disorder; a frequent tragic confusion. Menopause Int. 2012;18:65–7.

    Article  Google Scholar 

  19. Yonkers KA, Simoni MK. Premenstrual disorders. Am J Obstet Gynecol. 2018;1:68–74.

    Article  Google Scholar 

  20. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry. 2000;157:924–30.

    Article  CAS  Google Scholar 

  21. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal estrogen for the treatment of severe post-natal depression. Lancet. 1996;347:930–3.

    Article  CAS  Google Scholar 

  22. Dennis CL, Ross LE, Herxheimer A. Oestrogens and progestins for preventing and treating postpartum depression. Cochrane Database Syst Rev. 2008;4:CD001690.

    Google Scholar 

  23. Dennerstein L, Lehert P, Burger H, et al. Mood and the menopausal transition. J Nerv Ment Dis. 1999;187:685–91.

    Article  CAS  Google Scholar 

  24. Brincat M, Magos A, Studd JW, et al. Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study. Lancet. 1984;1:16–8.

    Article  CAS  Google Scholar 

  25. Soares CN, Almeida JH, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry. 2001;58:529–34.

    Article  CAS  Google Scholar 

  26. Montgomery JC, Brincat M, Tapp A, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet. 1987;1:297–9.

    Article  CAS  Google Scholar 

  27. Studd J. HRT should be considered as first line therapy for perimenopausal depression: FOR: estrogens are the first line treatment for perimenopausal women. BJOG. 2016;123:1011.

    Article  Google Scholar 

  28. Craig MC. HRT should be considered as first line therapy for perimenopausal depression: against: more clinical trials are needed. BJOG. 2016;123:1011.

    Article  Google Scholar 

  29. Gath D, Rose N, Bond A, et al. Hysterectomy and psychiatric disorder. Psychol Med. 1995;25:277–83.

    Article  CAS  Google Scholar 

  30. Khastgir G, Studd J. Patient’s outlook experience and satisfaction with hysterectomy bilateral oophorectomy and subsequent hormone replacement therapy. Am J Obstet Gynecol. 2000;183:1427–33.

    Article  CAS  Google Scholar 

  31. Studd J. Hysterectomy A life saving as well life enhancing operation. Menopause Int. 2009;15:2–3.

    Article  Google Scholar 

  32. Graziottin A, Serafini A. Depression and the menopause: why antidepressants are not enough? Menopause Int. 2009;15:76–81.

    Article  Google Scholar 

  33. Studd J. Hormone therapy for reproductive depression in women. Post Reprod Health. 2014;20(4):132–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John W. Studd .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 International Society of Gynecological Endocrinology

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Studd, J.W., Savvas, M., Watson, N. (2019). Reproductive Depression and the Response to Hormone Therapy. In: Brinton, R., Genazzani, A., Simoncini, T., Stevenson, J. (eds) Sex Steroids' Effects on Brain, Heart and Vessels. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-030-11355-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-11355-1_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-11354-4

  • Online ISBN: 978-3-030-11355-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics